// App-Quantinova.ai

e14555 : A pilot, phase I clinical trial to determine the biological effects of hydroxychloroquine (HCQ) on par-4 levels in patients with surgically removable solid tumors.

Researchers

Presenter

  • Peng Wang

Principal Investigators

  • Heidi Weiss

  • Susanne M. Arnold

  • John L. Villano

  • Mark Leggas

  • Vivek Rangnekar

Medical Centers

  • University of Kentucky Markey Cancer Center, Lexington, KY

  • University of Kentucky Markey Cancer Center, Lexington, KY

  • Markey Cancer Center, University of Kentucky, Lexington, KY

  • University of Kentucky, Lexington, KY

  • University of Kentucky, Lexington, KY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxychloroquine

Outcome

  • N/A

Study Design

  • Open Label

  • Dose Escalation

  • Cohort

Phase

  • I

Study Id's

  • NCT02232243

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved